ebomi
Colour theme
Sign in
Insider · CIK 0001606074

Svennilson Peter

CIK 0001606074 Name as filed on the most recent filing

Filed as Svennilson Peter (90)

254 transaction lines · from 90 filings · filed 2014-07-31 to 2026-02-26 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

90 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-02-25 S, Open-market sale Tenaya Therapeutics, Inc.TNYA 2 lines 1,975,051, disposed Open Form 4 filing 0001193125-26-076814
2026-02-24 S, Open-market sale Tenaya Therapeutics, Inc.TNYA 2 lines 405,138, disposed Open Form 4 filing 0001193125-26-076814
2026-02-23 S, Open-market sale Tenaya Therapeutics, Inc.TNYA 2 lines 182,743, disposed Open Form 4 filing 0001193125-26-067007
2026-02-20 S, Open-market sale Tenaya Therapeutics, Inc.TNYA 2 lines 322,044, disposed Open Form 4 filing 0001193125-26-067007
2026-02-11 S, Open-market sale Tenaya Therapeutics, Inc.TNYA 2 lines 2,761,715, disposed Open Form 4 filing 0001193125-26-049028
2026-02-10 S, Open-market sale Tenaya Therapeutics, Inc.TNYA 2 lines 280,507, disposed Open Form 4 filing 0001193125-26-049028
2026-02-06 P, Open-market purchase Eikon Therapeutics, Inc.EIKN 3 lines 38,119,680, acquired Open Form 4 filing 0001193125-26-043320
2026-01-20 P, Open-market purchase Surrozen, Inc./DESRZN 2 lines 353,817, acquired Open Form 4 filing 0001193125-26-016991
2026-01-16 P, Open-market purchase Surrozen, Inc./DESRZN 2 lines 51,240, acquired Open Form 4 filing 0001193125-26-016991
2026-01-15 P, Open-market purchase Surrozen, Inc./DESRZN 2 lines 236,540, acquired Open Form 4 filing 0001193125-26-016991
2026-01-14 P, Open-market purchase Surrozen, Inc./DESRZN 2 lines 110,395, acquired Open Form 4 filing 0001193125-26-014100
2026-01-13 P, Open-market purchase Surrozen, Inc./DESRZN 2 lines 246,957, acquired Open Form 4 filing 0001193125-26-014100
2026-01-06 P, Open-market purchase Surrozen, Inc./DESRZN 2 lines 300,297, acquired Open Form 4 filing 0001193125-26-007857
2023-11-16 P, Open-market purchase NGM Biopharmaceuticals IncNGM 3,627, acquired Open Form 4 filing 0000950170-23-064847
2023-11-15 P, Open-market purchase NGM Biopharmaceuticals IncNGM 11,880, acquired Open Form 4 filing 0000950170-23-064847
2023-01-31 P, Open-market purchase NGM Biopharmaceuticals IncNGM 883,403, acquired Open Form 4 filing 0000899243-23-003130
2023-01-30 P, Open-market purchase NGM Biopharmaceuticals IncNGM 37,707, acquired Open Form 4 filing 0000899243-23-003130
2023-01-23 P, Open-market purchase NGM Biopharmaceuticals IncNGM 49,494, acquired Open Form 4 filing 0000899243-23-002630
2023-01-20 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2,498, acquired Open Form 4 filing 0000899243-23-002375
2023-01-19 P, Open-market purchase NGM Biopharmaceuticals IncNGM 188,105, acquired Open Form 4 filing 0000899243-23-002375
2023-01-12 P, Open-market purchase NGM Biopharmaceuticals IncNGM 26,603, acquired Open Form 4 filing 0000899243-23-001854
2023-01-11 P, Open-market purchase NGM Biopharmaceuticals IncNGM 994,840, acquired Open Form 4 filing 0000899243-23-001694
2023-01-10 P, Open-market purchase NGM Biopharmaceuticals IncNGM 484,519, acquired Open Form 4 filing 0000899243-23-001694
2022-12-12 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,493, acquired Open Form 4 filing 0000899243-22-038465
2022-11-22 P, Open-market purchase NGM Biopharmaceuticals IncNGM 21,646, acquired Open Form 4 filing 0000899243-22-036912
2022-11-21 P, Open-market purchase NGM Biopharmaceuticals IncNGM 179,942, acquired Open Form 4 filing 0000899243-22-036912
2022-11-04 P, Open-market purchase NGM Biopharmaceuticals IncNGM 165,320, acquired Open Form 4 filing 0000899243-22-035274
2022-11-03 P, Open-market purchase NGM Biopharmaceuticals IncNGM 519,107, acquired Open Form 4 filing 0000899243-22-035274
2022-10-27 P, Open-market purchase NGM Biopharmaceuticals IncNGM 373,638, acquired Open Form 4 filing 0000899243-22-034559
2022-10-26 P, Open-market purchase NGM Biopharmaceuticals IncNGM 353,041, acquired Open Form 4 filing 0000899243-22-034352
2022-10-25 P, Open-market purchase NGM Biopharmaceuticals IncNGM 242,387, acquired Open Form 4 filing 0000899243-22-034352
2022-06-09 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 13,286,174, acquired Open Form 4 filing 0000899243-22-022212
2022-06-02 P, Open-market purchase NGM Biopharmaceuticals IncNGM 2 lines 445,739, acquired Open Form 4 filing 0000899243-22-021215
2022-06-01 P, Open-market purchase NGM Biopharmaceuticals IncNGM 1,196,566, acquired Open Form 4 filing 0000899243-22-020688

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 70
  • Open-market sale 20
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Svennilson Peter, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001606074

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.